These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 23758085)

  • 1. Histological factors for accurately predicting first locoregional recurrence of invasive ductal carcinoma of the breast.
    Hasebe T; Iwasaki M; Hojo T; Shibata T; Kinoshita T; Tsuda H
    Cancer Sci; 2013 Sep; 104(9):1252-61. PubMed ID: 23758085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Grading system for lymph vessel tumor emboli for prediction of the outcome of invasive ductal carcinoma of the breast.
    Hasebe T; Yamauchi C; Iwasaki M; Ishii G; Wada N; Imoto S
    Hum Pathol; 2008 Mar; 39(3):427-36. PubMed ID: 18261627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of mitotic figures in metastatic mammary ductal carcinoma to the lymph nodes.
    Hasebe T; Iwasaki M; Akashi-Tanaka S; Hojo T; Shibata T; Sasajima Y; Kinoshita T; Tsuda H
    Hum Pathol; 2011 Dec; 42(12):1823-32. PubMed ID: 21683981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Important histologic outcome predictors for patients with invasive ductal carcinoma of the breast.
    Hasebe T; Iwasaki M; Akashi-Tanaka S; Hojo T; Shibata T; Kinoshita T; Tsuda H
    Am J Surg Pathol; 2011 Oct; 35(10):1484-97. PubMed ID: 21881484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Grading system for blood vessel tumor emboli of invasive ductal carcinoma of the breast.
    Sugiyama M; Hasebe T; Shimada H; Takeuchi H; Shimizu K; Shimizu M; Yasuda M; Ueda S; Shigekawa T; Osaki A; Saeki T
    Hum Pathol; 2015 Jun; 46(6):906-16. PubMed ID: 25890786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A proposal for a new histological classification scheme for predicting short-term tumor recurrence and death in patients with invasive ductal carcinoma of the breast.
    Hasebe T; Imoto S; Sasaki S; Mukai K
    Jpn J Cancer Res; 1998 Dec; 89(12):1358-73. PubMed ID: 10081498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor histology in lymph vessels and lymph nodes for the accurate prediction of outcome among breast cancer patients treated with neoadjuvant chemotherapy.
    Tamura N; Hasebe T; Okada N; Houjoh T; Akashi-Tanaka S; Shimizu C; Shibata T; Sasajima Y; Iwasaki M; Kinoshita T
    Cancer Sci; 2009 Oct; 100(10):1823-33. PubMed ID: 19604245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of tumors in lymph vessels play an important role in the tumor progression of invasive ductal carcinoma of the breast: a prospective study.
    Hasebe T; Sasaki S; Imoto S; Ochiai A
    Mod Pathol; 2002 Sep; 15(9):904-13. PubMed ID: 12218207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histological characteristics of tumors in blood vessels play an important role in tumor progression of invasive ductal carcinoma of the breast.
    Hasebe T; Sasaki S; Imoto S; Ochiai A
    Cancer Sci; 2003 Feb; 94(2):158-65. PubMed ID: 12708491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of the intra-vessel tumor characteristics of invasive ductal carcinoma of the breast: a prospective study.
    Hasebe T; Sasaki S; Imoto S; Ochiai A
    Virchows Arch; 2004 Jan; 444(1):20-7. PubMed ID: 14624360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atypical tumor-stromal fibroblasts in invasive ductal carcinoma of the breast.
    Hasebe T; Iwasaki M; Akashi-Tanaka S; Hojo T; Shibata T; Sasajima Y; Kinoshita T; Tsuda H
    Am J Surg Pathol; 2011 Mar; 35(3):325-36. PubMed ID: 21317705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival benefit of post-mastectomy radiotherapy in breast carcinoma patients with T1-2 tumor and 1-3 axillary lymph node(s) metastasis.
    Duraker N; Demir D; Bati B; Yilmaz BD; Bati Y; Çaynak ZC; Sobutay E
    Jpn J Clin Oncol; 2012 Jul; 42(7):601-8. PubMed ID: 22511807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Grading system for lymph vessel tumor emboli: significant outcome predictor for patients with invasive ductal carcinoma of the breast who received neoadjuvant therapy.
    Hasebe T; Tamura N; Iwasaki M; Okada N; Akashi-Tanaka S; Hojo T; Shimizu C; Adachi M; Fujiwara Y; Shibata T; Sasajima Y; Tsuda H; Kinoshita T
    Mod Pathol; 2010 Apr; 23(4):581-92. PubMed ID: 20118911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histological characteristics of tumor in vessels and lymph nodes are significant predictors of progression of invasive ductal carcinoma of the breast: a prospective study.
    Hasebe T; Sasaki S; Imoto S; Ochiai A
    Hum Pathol; 2004 Mar; 35(3):298-308. PubMed ID: 15017585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and pathological factors influencing survival in a large cohort of triple-negative breast cancer patients.
    Urru SAM; Gallus S; Bosetti C; Moi T; Medda R; Sollai E; Murgia A; Sanges F; Pira G; Manca A; Palmas D; Floris M; Asunis AM; Atzori F; Carru C; D'Incalci M; Ghiani M; Marras V; Onnis D; Santona MC; Sarobba G; Valle E; Canu L; Cossu S; Bulfone A; Rocca PC; De Miglio MR; Orrù S
    BMC Cancer; 2018 Jan; 18(1):56. PubMed ID: 29310602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrotic focus in invasive ductal carcinoma of the breast: a histopathological prognostic parameter for tumor recurrence and tumor death within three years after the initial operation.
    Hasebe T; Tsuda H; Tsubono Y; Imoto S; Mukai K
    Jpn J Cancer Res; 1997 Jun; 88(6):590-9. PubMed ID: 9263537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are there patients with T1 to T2, lymph node-negative breast cancer who are "high-risk" for locoregional disease recurrence?
    Mamtani A; Patil S; Stempel MM; Morrow M
    Cancer; 2017 Jul; 123(14):2626-2633. PubMed ID: 28334423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of nodal metastatic tumor characteristics in nodal metastasis and prognosis of patients with invasive ductal carcinoma of the breast.
    Hasebe T; Sasaki S; Imoto S; Ochiai A
    Cancer Sci; 2003 Feb; 94(2):181-7. PubMed ID: 12708494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy.
    Truong PT; Olivotto IA; Kader HA; Panades M; Speers CH; Berthelet E
    Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1337-47. PubMed ID: 15817335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Grading system for lymph vessel tumor emboli: significant outcome predictor for invasive ductal carcinoma of the breast.
    Hasebe T; Okada N; Iwasaki M; Akashi-Tanaka S; Hojo T; Shibata T; Sasajima Y; Tsuda H; Kinoshita T
    Hum Pathol; 2010 May; 41(5):706-15. PubMed ID: 20060154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.